Timeline

Stocks in Action USA: IBM, Amazon, Zeta Global

AI Correction Rocks Global Markets – Chip Rout Begins in Asia, Kospi Crashes, SK Hynix and Samsung Each Lose Over 9% – Nasdaq ...

Walmart

Walmart: Ambitious Transformation into a Technology Platform

Jenoptik

Jenoptik: Chip equipment manufacturer breaks out to a 52-week high amidst sector correction. How the semiconductor boom fuels growth.

Jörg Meyer

Chevron

Chevron – Oil Giant Becomes Electricity Supplier for Microsoft's AI Data Centers in Texas!

Novo Nordisk exits the consolidation phase. Here are three reasons why.

MTU Aero Engines

MTU: The Quality Stock is on Its Way Back to Levels of €400

Amazon.com

Amazon – the Prime Day becomes a litmus test for the costly AI strategy!

Zeta Global Holdings

Zeta Global: Palantir Partnership for Agent-Based Marketing as a Catalyst for Growth

Coca-Cola

Coca-Cola: Potential Tax Liability in the Double-Digit Billion Range Goes to Appeals ...

Stocks in Action: RWE, Brenntag, DWS Group, Vonovia, and Deutsche Lufthansa.

Martin Springman

D-Wave Quantum: US Government Signs Decrees to Strengthen US Leadership in Quantum Computing!

TOP-5 Analyst Price Targets as of 23.06.26

Palantir Technologies

Palantir – AI Data Specialist Enlists Zeta Global in Marketing Endeavor, But Stock Struggles!

Amazon.com

Amazon – E-commerce Giant Turns Prime Day into a Stress Test for Its Shopping AI!

NVIDIA

NVIDIA – AI Stock Favorite Comes Under Pressure: Goldman Sachs Warns of Overheating in the Billion Dollar Market for Artificial ...

DAX under pressure after weak signals from Asia and the USA - Chip stocks in decline ...

Zebra Technologies

Zebra Technologies Presents the new CV70 CXP Idustrial Camera at Automate 2026!

Andreas Zehetner

Tenax Therapeutics

Tenax Therapeutics Approaching Crucial Study Data: Experts See High Potential in the Cardiopulmonary Portfolio

QUALCOMM

Qualcomm Targets Nvidia. The Potential $4 Billion Acquisition of Modular is a bet on the Future of AI!

Fortinet

Fortinet on the Rise Thanks to Quantum Decree! Trump Focuses on Quantum-Safe Encryption!

Washington's Double Hit: Quantum and AI Stocks Become Major Winners!

International Business Machines

IBM as a Quantum Computing Pioneer - US Government Plans Quantum Computers by 2028!

Chevron

Chevron: The Oil Giant is Fueling the AI Revolution with Permian Gas – and has Been...

US Eases Iran Sanctions After Initial Peace Talks - Super Micro Soars Over 15% Thanks to Nvidia Power and SpaceX Fantasies - Alphabet Stock Falls 5% After Dramatic Loss of AI Talent - Qualcomm Explores Next AI Chip Deal

Thorsten Reich

Military Contracts at Record Speed! Rocket Lab Embarks on the Journey into Operational Weightlessness!

Alphabet's AI Dilemma! Departure of two key Talents Costs the Company Billions of Dollars!

Super Micro Computer

The Super Micro Stock Jumps by Over 15%! Major Orders and new Hardware Drive the Stock!

Commentary on our rankings

Take-Two Interactive Software

Accumulation

Take-Two Interactive: GTA VI Pre-orders Ignite Stock Surge

Hinge Health

Accumulation

Hinge Health: AI Growth and Record Price Target Fuel Massive Rally

MYR Group

All-Time High

MYR Group Benefits from Record Order Backlog in Power Grid Expansion!

Smith & Wesson Brands

Pivotal-Point Tracking Smith & Wesson Brands (SMBI): Q4 Revenue Rises by Nearly 27% - US Traditional Manufacturer Gains Market Sha...

AmpliTech Group

Pivotal-Point Tracking AmpliTech Group (AMPG): Technology leader shines as the only p...

Enliven Therapeutics

Nicolas-Darvas Breakouts

Enliven Therapeutics: The Cancer Specialist on the Brink of the Final Study Step

David Engelhardt

Vicor

Vicor (VICR) in our Pivotal Point Check: Power Specialists with Explosive AI Order Growth - Price Target Raised by Needham to $400!

Celsius Holdings

Seasonalities

Celsius Holdings: Summer Heat Drives Energy Drink Demand

SPX Technologies

Industries and Sectors

SPX Technologies: The Coldest Business in the Hottest Market! SPX Provides Cooli...

Precigen

Top Growth Stocks Revenue

Precigen: Specialist in Immunotherapies Secures US Market Exclusivity for PAPZIMEOS Until 2032!